Cipla gets approval for generic version of Renvela tablets from USFDA
Cipla’s subsidiary InvaGen Pharmaceuticals Inc has received nod from the US health regulator for Sevelamer Carbonate tablets, which are suggested for the control of serum phosphorus in...